topical cannabidiol

This specific topical formulation of cannabidiol (CBD) is an investigational transdermal cream developed by the Louisiana State University Health Sciences Center Shreveport. It is being evaluated for its efficacy in reducing chronic musculoskeletal joint pain, specifically targeting patients who are either using or considering opioid therapy. As a non-psychoactive cannabinoid, CBD is thought to exert analgesic and anti-inflammatory effects through complex interactions with the endocannabinoid system, including modulation of cannabinoid receptors (CB1 and CB2), TRPV1 channels, and various non-cannabinoid G protein-coupled receptors. The transdermal delivery route aims to provide localized relief while minimizing systemic exposure and avoiding the gastrointestinal or hepatic metabolism associated with oral administration.

Other names

Topical CBD creamTransdermal Cannabidiol